Clinical and economic rationale for the choice of treatment method for patients with kidney stones 10-20 mm


Cite item

Full Text

Abstract

The clinical and economic rationale for choosing a method of treating patients with kidney stones 10-20 mm in size is presented. Remote lithotripsy was found to be effective in 94,2% of patients whose urolitic density is less than 1000HU and in 81.6% of patients who have a stone density of more than 1000 HU. A «stone free state» with standard and mini- percutaneous nephrolitholapaxia was achieved in 93,5 and 94,1% in patients with a stone density of more than 1000 HU. Uroliths with a density of less than 1000 HU were removed in all patients using standard percutaneous nephrolitholapaxia and in 95% of patients using mini percutaneous nephrolitholapaxia. The smallest direct medical costs were observed when performing remote lithotripsy (patients with a density of uroliths less than 1000 HU - 24292,4 rubles, patients with a density of stones more than 1000 HU - 36930 rubles). When performing operations of standard and mini-nephrolitholapaxia, the cost of treatment was 38715,7 and 35900 rubles. for patients with uroliths with a density of less than 1000 HU, 40024 and37312,8 rubles. in patients with uroliths with a density of more than 1000 HU. The cost increment coefficient showed that additional costs of 1% of the treatment efficiency when using the minipercutaneous technique will require 30,6 rubles, with standard nephrolitholapaxy - 260 rubles per person compared with distance lithotripsy. From the standpoint of clinical and economic analysis, the mini-and standard percutaneous nephrolitholapaxia should be considered as reasonable methods for the surgical treatment of patients with high-density stones of 1-2 cm, remote lithotripsy is the first-line method for the treatment of calculi of lower density.

About the authors

V V Protoshak

Военно-медицинская академия им. С.М. Кирова

Email: vmeda-nio@mil.ru
Санкт-Петербург

V Yu Tegsa

Военно-медицинская академия им. С.М. Кирова

Email: vmeda-nio@mil.ru
Санкт-Петербург

M V Paronnikov

Военно-медицинская академия им. С.М. Кирова

Email: vmeda-nio@mil.ru
Санкт-Петербург

D N Orlov

Военно-медицинская академия им. С.М. Кирова

Email: vmeda-nio@mil.ru
Санкт-Петербург

S A Alentiev

Военно-медицинская академия им. С.М. Кирова

Email: vmeda-nio@mil.ru
Санкт-Петербург

M V Lazutkin

Военно-медицинская академия им. С.М. Кирова

Email: vmeda-nio@mil.ru
Санкт-Петербург

References

  1. Аляев, Ю.Г. Мочекаменная болезнь. Современные методы диагностики и лечения / Ю.Г. Аляев [и др.]. - М.: ГЭОТАР- Медиа, 2010. - 224 с.
  2. Аляев, Ю.Г. Урология. Российские клинические рекомендации / Ю.Г. Аляев. - М.: Медфорум, 2017. - 544 с.
  3. Аполихин, О.И. Заболеваемость мочекаменной болезнью в Российской Федерации (2005-2016 годы) / О.И. Аполихин [и др.] // Эксп. и клин. Урология. - 2018. - № 4. - С. 4-14.
  4. Арустамян, Г.Н. Клинико-экономический анализ и его роль в управлении качеством медицинской помощи / Г.Н Арустамян // Гос. упр. Электрон. вестн. - 2011. - № 29. - С. 2-10.
  5. Владимирский, М.М. Пути оптимизации медицинской помощи больным мочекаменной болезнью: автореф. дис. … канд. мед. наук / М.М. Владимирский. - М., 2005. - 34 с.
  6. Воробьев, П.А. Клинико-экономический анализ / П.А. Воробьев [и др.]. - М.: Ньюдиамед, 2008. - 778 с.
  7. Вялкова, А.И. Оценка эффективности деятельности медицинских организаций / А.И. Вялкова [и др.]. - М.: ГЭОТАР-Медиа, 2004. - 112 с.
  8. Отраслевой стандарт «Клинико-экономические исследования. Общие положения». ГОСТ Р 57525-2017. - М.: Стандартинформ, 2017. - 22 с.
  9. Решетникова, А.В. Экономика и управление в здравоохранении / А.В. Решетникова, Н.Г. Шамшурина, В.И. Шамшурин. - М.: Юрайт, 2017. - 197 с.
  10. Шестаев, А.Ю. Эндоскопические методы лечения мочекаменной болезни / А.Ю. Шестаев [и др.]. - СПб.: ВМА, 2017. - 46 с.
  11. Geraghty, R. Worldwide trends of urinary stone disease treatment over the last two Decades: a systematic review / R. Geraghty, P. Jones, B. Somani // J. Endourol. - 2017. - № 6 (31). - P. 547-556.
  12. Chan, L.H. Primary SWL is an efficient and cost-effective treatment / L.H. Chan [et al.] // J. Endourol. - 2017. - № 5 (31). - P. 510-516.
  13. Chung, V.Y. The success of shock wave lithotripsy (SWL) in treating moderate-sized (10-20 mm) renal stones / V.Y. Chung, B.W. Turney // Urolithiasis. - 2016. - № 5 (44). - P. 441-444.
  14. De La Rosette, J. CROES PCNL Study Group. The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications and outcomes in 5803 patients / J. De La Rosette [et al.] // J. Endourol. - 2011. - № 1 (25). - P. 11-17.
  15. Jackman, S.V. Miniaturized access for pediatric percutaneous nephrolithotomy / S.V. Jackman, S.P. Hedican, S.G. Docimo // J. Endourol. - 1997. - № 11. - P. 133.
  16. Neisius, A. What is the current status of shock wave lithotripsy? / A. Neisius // Urologe A. - 2017. - № 9 (56). - P. 1147-1157.
  17. Pietropaolo, A. Trends of urolithiasis: interventions, simulation, and laser technology over the last 16 years (2000-2015) as published in the literature (PubMed): a systematic review from European section of Urotechnology (ESUT) / A. Pietropaolo [et al.] // World J. Urol. - 2017. - № 11 (35). - P. 1651-1658.
  18. Turk, C. EAU Guidelines on interventional treatment for urolithiasis / C. Turk [et al.] // Eur. Urol. - 2016. - № 3 (69). - P. 475-482.
  19. Yuri, P. Meta-analysis of Optimal Management of Lower Pole Stone of 10-20 mm: Flexible Ureteroscopy (FURS) versus Extracorporeal Shock Wave Lithotripsy (ESWL) versus Percutaneus Nephrolithotomy (PCNL) / P. Yuri [et al.] // Acta Med. Indones. - 2018. - № 1 (50). - P. 18-25.
  20. Zhang, H. Comparison of the Efficacy of Ultra-Mini PCNL, Flexible Ureteroscopy, and Shock Wave Lithotripsy on the Treatment of 1-2 cm Lower Pole Renal Calculi / H. Zhang [et al.] // Urol. Int. - 2019. - № 2 (102). - P. 153-159.

Copyright (c) 2020 Protoshak V.V., Tegsa V.Y., Paronnikov M.V., Orlov D.N., Alentiev S.A., Lazutkin M.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies